Product
HS-20105
1 clinical trial
1 indication
Indication
Advanced Solid TumorClinical trial
Phase I Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic and the Therapeutic Potential of HS-20105 for Injection in Patients With Advanced Solid Tumors.Status: Not yet recruiting, Estimated PCD: 2026-03-01